MONICA PATIN: Open Payments
NPI 1790789667 · OGALLALA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 44 payments from 11 companies in 2025. Trend: 2023 $1,161 · 2024 $934 · 2025 $850
Food & beverage: $850
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $341 |
| Amgen Inc. | 12 | $199 |
| AstraZeneca Pharmaceuticals LP | 4 | $99 |
| UCB, Inc. | 3 | $48 |
| Janssen Biotech, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Sandoz Inc. | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: RINVOQ, SKYRIZI, TAVNEOS, ENBREL, Bimzelx, KRYSTEXXA, OTEZLA, TREMFYA.
Industry payments across NE — which companies pay providers there.
